Phase III Randomized Trial of Standard Systemic Therapy SST versus Standard Systemic Therapy Plus Definitive Treatment Surgery or Radiation of the Primary Tumor in Metastatic Prostate Cancer
Randomized Phase II Trial of Niraparib with Standard Combination Radiotherapy and Androgen Deprivation Therapy ADT in High Risk Prostate Cancer with Initial Phase I NADIR Randomized Phase II Trial of Niraparib with Standard Combination Androgen Deprivation Therapy ADT and Radiotherapy in High Risk Prostate Cancer with Initial Phase I
A Phase II Multiple-Dose, Multiple-Arm, Parallel Assignment Study to Evaluate the Safety,
Tolerability, and Preliminary Efficacy of XmAb20717 Alone or in Combination with
Chemotherapy or Targeted Therapies in Selected Subjects with Metastatic Castration-Resistant
Prostate Cancer
A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study ICON study number: 0798/0661
NRG-GU009: Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation PREDICT-RT
Sleep Hygiene Education, ReadiWatchTM Actigraphy, And Telehealth Cognitive Behavioral Training For Insomnia Effect, On Symptom Relief For Men With Prostate Cancer Receiving Androgen Deprivation Therapy ADT SHERE-Relief 2.